artenimol has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Fei, M; Niu, W; Wang, H; Wang, X; Yao, L; Yi, R; Zhaba, W | 1 |
| Blaes, J; Dong, Z; Green, E; Hertenstein, A; Jugold, M; Lemke, D; Löw, S; Ott, M; Platten, M; Pledl, HW; Sahm, F; Steffen, AC; Weiler, M; Wick, W; Winkler, F; Zorn, M | 1 |
| Hu, Y; Liu, X; Liu, Y; Ma, J; Qu, C; Que, Z; Wang, P; Xue, Y | 1 |
3 other study(ies) available for artenimol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.
Topics: Antineoplastic Agents, Phytogenic; Artemisinins; Brain Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Ferroptosis; Glioblastoma; Humans; Phospholipid Hydroperoxide Glutathione Peroxidase; Reactive Oxygen Species; Receptors, Transferrin; Signal Transduction | 2020 |
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy.
Topics: Animals; Antimalarials; Artemisinins; Brain Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Mice; Mice, Nude; Oxidative Stress; Physical Conditioning, Animal; Reactive Oxygen Species; Temozolomide | 2016 |
Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling.
Topics: Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Glioblastoma; Humans; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Reactive Oxygen Species; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2017 |